Rx.Health’s leading digital medicine platform is now enabling the Mount Sinai AppLab and the American Gastroenterology Association to collect electronic Patient Reported Outcomes (e-PROs) for an NIH-Funded Registry for Fecal Microbiota Transplantation (FMT). The FMT registry is expected to enroll and engage with 4000 patients from 65 sites in leading healthcare systems throughout North America over the next 10 years.
This collaboration is a great model of how Rx.Health can partner with medical societies and industry to create customized digital care and research plans. By using its proprietary AI and Clinical Rules Engine Rx.Health creates a continuous engagement model, reduces drop-outs, and enables the collection of real world evidence from patient and device generated data for novel devices, drugs, and digital therapeutics.To Learn more, contact engage@Rx.Health
As digital medicine continues to serve as a driving force in the evolution of patient care, Rx.Health is announcing, in partnership with the AppLab at Mount Sinai, the release of a transformative Gastrointestinal Digital Medicine Toolkit at Digestive Disease Week 2018 in Washington, DC. This end-to-end solution is the first of its kind in the field of gastroenterology, and allows both patients and providers to realize the myriad of benefits from combining multiple proven and complimentary digital solutions in a single toolkit for GI diseases and endoscopy procedures.
The Toolkit allows providers to prescribe patients a care plan that evolves with the patient’s condition. Included in the offering are clinically-proven tracking apps, telemedicine support services, scheduling and feedback reminders, as well as solutions that provide a holistic approach to patient care, such as patient social outreach engagement and ongoing health education materials. An additional core component of the Toolkit is HealthPROMISE, an app-based platform developed at Mount Sinai that is designed to improve the quality of care for those patients struggling with inflammatory bowel disease.
When asked about the significance of the GI Digital Medicine Toolkit, Pavan Choksi, who serves as Rx.Health’s Vice President of Corporate Development and Transformation Lead, noted that “Digital Medicine presents a unique opportunity for providers to treat patients on a continual basis, and not just during office hours. But like anything, you need the right mechanism in place to do this effectively. The Toolkit combines the strongest offerings that are complimentary with one another to optimize not just procedural outcomes, but also the general patient experience.”
In conjunction with the release of the GI Digital Medicine Toolkit, Mount Sinai’s AppLab will be presenting the results of a two-year clinical trial of HealthPROMISE on Saturday, June 2nd, at the Mount Sinai Booth at DDW. In addition to the presentation, representatives from AppLab will also be demonstration of the unique GI BOT. Please stop by booth #1407 to discuss how digital medicine could transform your practice or care.
Rx.Health CEO and cofounder Ed Berde recently sat down with Enterprise Radio host Eric Dye to discuss his current work, as well as past ventures, in an effort to relay advice to aspiring entrepreneurs. Berde discussed how he embraced an alternative career path early in his career, which began when he made the decision to leave the comforts of a highly respected consulting firm to pursue his first venture.
Berde also offered insight into how Rx.Health differs from his past ventures from the perspective of an entrepreneur, starting with the credibility associated with the company’s roots in the Mount Sinai Health System, which has seven hospital campuses in the New York metropolitan area.
“Rx.Health already had some serious advantages at the outset that any entrepreneur would immediately recognize,” Berde said. “In the healthcare industry, establishing credibility is everything. It’s kind of a catch 22 for entrepreneurs. They’ll never get into health systems without landing a major health system first, but you’ll never land that first major health system because you’re not in any health systems already.”
Berde extended an invitation to new entrepreneurs who are seeking advice to reach out through LinkedIn so that he can talk through the classic struggles of an entrepreneur and field any questions where he can offer expertise.
Berde’s interview was featured on Enterprise Radio broadcast by the Entrepreneur Podcast Network on Monday, Dec. 18.
Leveraging technology to advance remote patient monitoring (RPM) has the potential to unlock efficiencies for clinicians in the areas of patient outreach, identification of at-risk patients, an improvement in care initiatives. A recent article featured in MedCity News not only highlighted these potential benefits but also detailed CMS’ current and suggested future efforts to support RPM.
The article advocates for the removal of the existing barriers actively preventing the widespread adoption of digital technologies as a means to better care. Medicare reimbursement for telehealth and remote patient monitoring technologies totaled just $28.75 million in 2016, less than 3 percent of CMS’ annual budget. Despite the statistics, CMS has taken an important first step in recognizing the value of RPM technologies.
In November, CMS announced that it will support and reimburse providers using remote monitoring technologies in 2018. In furtherance of these efforts, CMS will unbundle and activate CPT code 99091 (collection and interpretation of physiologic data) from the traditional chronic care management programs. This will allow provider reimbursement for time spent collecting and analyzing health data that is generated by patients, digitally stored, and transmitted to the providers. Further, CMS should recognize the equipment, facilities, non-physician medical staff, and technologies that are required to drive these innovations to scale and provide robust reimbursement for these services.
Given the trends in the healthcare market, and CMS’ reaction to those market forces, healthcare organizations should start adopting RPM technologies to benefit from these regulatory incentives. Such incentives will continue to grow as healthcare providers further embrace digital solutions and CMS recognizes the benefits of those technologies to patient populations, particularly in underserved or remote areas.
Rx.Health is excited to serve as an ecosystem partner at NODE Health’s inaugural Digital Medicine Conference at the Microsoft Technology Center in Times Square beginning on Dec. 4. The company will join its academic partners including the APPLab at Icahn School of Medicine at Mount Sinai to support the first ever multi-stakeholder meeting on the scientific evidence for digital innovation. Other leading names in healthcare innovation, such as UCSF, Stanford, Northwell, LifeBridge Health and Yale New Haven Health, will also be in attendance for the event.
During the conference, Rx.Health’s team will be providing a demonstration to attendees of the RxUniverse platform. The demonstration will highlight the platform’s seamless digital solution as attendee’s, including industry executives, will be prescribed a survey dedicated to gather relevant information regarding how the platform can drive innovation and Digital Medicine transformation in any health system.
“As a company that is singularly focused on evidence-based Digital Medicine, we’ve been looking forward to this conference for quite some time,” said Ed Berde, the CEO of Rx.Health. “Anytime my team can get in a room to talk with other innovators in the field, let alone the top health systems promoting clinically proven innovation, we’re eager to discuss what’s worked and what hasn’t, and how those successes and failures are formulating experts’ vision of the future of Digital Medicine.”
Rx.Health will also be presenting the successful results of three distinct studies with academic partners that adopted RxUniverse as a focal point in each study. The first study presented will be the RxUniverse pilot study program, which was recently profiled at the American Medical Informatics Association’s 2017 Annual Symposium. As previously reported, RxUniverse ranked in the 96th percentile on Usability.gov’s System Usability Scale among all technology products. At the conclusion of the study clinicians exceeded digital prescription expectancies by more than 200 percent.
The second study focused on patients who employed Digital Medicine solutions through the RxUniverse platform to manage Chronic Heart Failure. The study, which was conducted at Mont Sinai, found that patients monitoring their condition through a clinically proven app were significantly less likely to be readmitted to the hospital within the first 30 days after a procedure. Among participants, the readmission rate during the study was just 10 percent, compared to Mount Sinai’s average of 22.8 percent and the national average of 25 percent.
The Rx.Health team will present a final study involving patients suffering from inflammatory bowel disease. During the study, these patients were prescribed with HealthPROMISE, a unique, cloud-based patient reported outcome and decision support tool. Patients were asked to use HealthPROMISE to report on their quality of life measures during a two-year trial sponsored by the National Institutes of Health. 320 patients with IBD were prescribed with app-based digital technologies to aid in their care. At the conclusion of the study, which was featured in MobiHealth News, patients prescribed with HealthPROMISE were found to have reported a significantly higher quality of life.
NODE Health Foundation is the society of Digital Medicine. At the heart of the foundation, is a consortium comprised of over 20 health systems and over 7,000 Digital Medicine enthusiasts, all sharing the singular goal of evaluating the cross-section of evidence based medicine with emerging healthcare technologies in an effort to promote the proliferation and efficacy of evidence-based Digital Medicine.